Adverse Selection

Adverse selection is the statistical tendency of people who know they are at higher-than-average risk to buy more insurance, and at higher amounts, than people who know they are at lower risk. It is a direct consequence of asymmetric information — the applicant usually knows more about their own health, driving habits, and home safety than the insurer does — and it can destabilise an insurance pool if not actively managed. The classic Indian example is health insurance for senior citizens: buyers above 60 with recent diagnoses are far more motivated to buy than healthy seniors, and without underwriting controls the pool would be dominated by higher-risk entrants, driving claim costs up, forcing premium increases, and causing the healthier buyers to exit — the 'death spiral' economists describe.

Indian insurers counter adverse selection through several mechanisms. Waiting periods on pre-existing conditions (24-48 months) delay payouts on known ailments so a pool-and-exit strategy is unattractive. Medical underwriting for sum assureds above a threshold screens out the most adversely selected applicants.

Lifetime-renewable clauses, mandated by IRDAI for health insurance, allow renewal at later ages so healthy young buyers are not penalised for loyalty. Age-banded pricing ensures each cohort pays roughly its expected claim cost, rather than cross-subsidising higher-risk cohorts. Worked example: imagine two hypothetical health pools — Pool A with flat ₹10,000 annual premium regardless of age, Pool B with age-banded pricing from ₹6,000 at 25 to ₹35,000 at 65.

Pool A initially looks attractive to healthy young buyers, but within three years the under-40s leave for Pool B's cheaper option, leaving Pool A with a higher-claims, older population, and premiums must be raised to ₹18,000, triggering further exits — the adverse-selection spiral. Pool B, by charging each age cohort its expected cost, remains actuarially stable. A common misconception is that adverse selection is the buyer's fault or moral failing.

It is not — it is rational behaviour in response to an information gap, and the onus is on the insurer to design the product and the underwriting to price it accurately. Another common misconception is that adverse selection disappears once the policy is issued. It continues to matter for renewal decisions — buyers who experience a new diagnosis are more likely to renew, while buyers who stay healthy are more likely to shop, so insurers monitor retention patterns by claim-experience cohort and adjust pricing accordingly.

Related: moral hazard, underwriting, waiting period.